Medications

Few patients use weight-loss medications despite FDA approval

Despite guidelines that advocate the use of weight loss medications to treat obesity, and the availability of FDA approved medications, very few patients use this treatment option, a new study suggests. The results will be ...

Diseases, Conditions, Syndromes

High-dose sugammadex speeds reversal of neuromuscular block

(HealthDay)—Sugammadex at a dose of 4 mg/kg−1 of ideal body weight allows for shorter reversal of deep neuromuscular blockade in morbidly obese patients, according to a study published in the March issue of Anaesthesia.

Diabetes

NAFLD linked to unfavorable metabolic profile in T2DM

(HealthDay)—For obese patients with type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD) is associated with an unfavorable metabolic profile, according to a study published online Feb. 9 in Diabetes ...

Oncology & Cancer

Why prostate cancer is more aggressive in obese patients

Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known. Researchers from the Institut de Pharmacologie et Biologie ...

page 23 from 40